INTRODUCTION:

One of the top gynaecologic oncologists in the nation, Dr. Rupinder Sekhon specializes in ovarian cancer and uses HIPEC and cytoreductive surgery for ovarian cancer that has returned. She has a long medical history of cervical and endometrial cancer procedures. Her contribution has been crucial in elevating the gynaecology department to the highest level in the nation, encompassing advanced procedures such as hysteroscopy, laparoscopy, colposcopy, and open and robotic gynaecologic surgery. Since 2011, she has been a Certified Robotic Console Surgeon and has completed numerous robotic procedures for various gynaecological malignancies. She spent more than 16 years as a Classified Specialist Obs & Gynae in the Indian Air Force.

President

• AOGIN – India (Asia-Oceania Research Organisation in Genital Infection and Neoplasia)
• ELECT AGOI (Association of Gynaecologic Oncologists of India)

Qualifications

• MD PGIMER, Chandigarh
• DGO, Govt. Medical College, Amritsar, Punjab
• MBBS, Govt. Medical College, Amritsar, Punjab
• Diploma in Advanced Hysteroscopy and Laparoscopy (Germany)
• Certified Robotic Gynae Surgeon (USA)
• FICOG (Fellow of Indian Colleges of Obstetricians and Gynaecologists)

Expertise

• HIPEC, PIPEC and HITHOC.
• Secondary cytoreductive surgery in ovarian cancer.
• Recurrences in cancer endometrium.
• Radical Vulvectomy with Inguinal Lymph node Dissection and other complex surgeries for vaginal & vulvar cancer.
• Robotic Radical Hysterectomy, Pelvic Lymph Node Dissection, Retroperitoneal Lymph Node Dissection, Staging Laparotomy, Sentinel Lymph Node Dissection.

Awards & Achievements

• First to be trained in Robotic surgery in Gynae Oncology at Connecticut, USA.
• First to perform Peritonectomy and HIPEC in Ovarian cancer in North India.
• Invited Speaker at MD Anderson Cancer Centre, Texas, USA.
• IARC-IFCPC – Certified Trainer in colposcopy.
• Advisory Board Member – MSD & GSK for HPV Vaccine.
• Delivered key note addresses & chaired various national and international conferences.
• Initiated PIPAC – HITHOC for Interval Cytoreductive Surgery in ovarian cancer.
• Commendation Award on 26 January Republic Day of India by Commander- in- Chief Air Force for Professional Excellence.
• Best Gynaecologic Oncologist Delhi 2012, Awarded by Times Research Media.

Memberships

• Member Ethics Committee ICPO (Institute of Cytology and Preventive Oncology)
• Member Oncology Committee AOGD
• Member Scientific Committee – IGCS 2016
• Visiting Fellow Memorial Sloan Kettering Cancer Centre, USA
• FOGSI (Federation of Obstetric and Gynaecological Societies of India)
• ISOPARB (Indian Society of Perinatology and Reproductive Biology)
• IAGES (Indian Association of Gastrointestinal Endo surgeons)
• ISCCP (International Satellite Cloud Climatology Project)
• Executive Member ISCCP
• Executive Member IAGES
• Advisor Gynae Oncology Group
• ADHD (attention deficit hyperactivity disorder)
• Member IRB (Institutional Review Board) Rajiv Gandhi Cancer Institute and Research Centre (2017 – 2023)

Trials

• Collaborator LACC Trial – Open Vs Robotic / Laparoscopic Radical Hysterectomy in collaboration with MD Anderson Cancer Centre USA and Queensland Cancer Centre Australia.
• PDT- Use of PDT in Early Cervical Pre cancer Lesion- Pilot Study.
• Associate Investigator Pilot Study – Human Papillomavirus Genotype Distribution in Cervical Cancer In India Result from a multi Center Study.

Publications

• Sekhon R, Bhatla N. Gynecological cancer update. Asian Journal of Oncology. 2016 Jul 1;2(2):61.
• Modi KB, Rawal S, Suhas KR, Giri S, Jain V, Sekhon R, Bora RR, and Giri S.An Examination of the Function of PET/CT in Recurrent Ovarian Cancer in a Tertiary Healthcare Facility.Gynecologic Oncology in India. Sep. 1, 2016; 14(3):1-6.
• Batra K, Shah SH, Rawal S, Hassan N, Jain V, Sekhon R, Giri S, and Batra K.Our Experiences and Interim Outcomes with Robotic-Assisted Video Endoscopic Inguinal Lymphadenectomy for Carcinoma Vulva.Gynecological Cancer International Journal. 2017 Jan 1;27(1):159-65.
• Batra Modi K, Rawal S, Mitra S, Jain V, Shah S, Giri S, and Sekhon R.Clinicopathologic Prognostic Factors for Recurrent Vulva Cancer, Recurrence Patterns, and Their Management.Journal of Gynecologic Surgery, 32(6), 339–44, Dec. 1, 2016.
• Rawal S, Shukla H, Jain V, Batra K, Shah SH, Giri S, and Sekhon R.The Inguinal Lymphadenopathy in Ovarian Cancer: Presentation and Treatment.Indian Journal of Surgical Oncology 7(4):436–40, Dec. 1, 2016.
• Batra K, Bajracharya A, Rawal S, Bora RR, Giri S, Sekhon R, and Jain V.Our Experience with the Role of Radical Surgery in the Early Stages of Vaginal Cancer.International Journal of Gynecological Cancer, 26(6), 1176–81, published July 1, 2016.
• Jain V, Sekhon R, Rawal S, Rajappa SK, Shukla H, Shah SH, Batra Modi K, Shukla H, and Shrestha E.A prospective single-institution study examining the variables influencing the perioperative results following CRS and HIPEC for advanced and recurrent ovarian cancer.Journal of Gynecologic Surgery, 33(1), 4–11, Feb. 1, 2017.
• Giri S, Rawal SK, Wani NH, and Sekhon R.Ovarian hepatoid carcinoma: an extremely uncommon histological finding.International Journal of Obstetrics, Gynecology, Contraception, and Reproduction.2017 Jan 4;3(3):824-6.
• Rawal S, Giri S, Lal P, and Sekhon R.An ovarian cancer patient may undergo a routine appendicectomy as part of the surgical staging process.International Journal of Obstetrics, Gynecology, Reproduction, and Contraception. 2016 Dec 7;5(12):4263-5.
• Leblanc E, Bresson L, Hudry N, Sekhon R, Narducci F.Surgery was performed on the obese patient for early-stage endometrial cancer.On July 1, 2016, Asian Journal of Oncology, 2(2), 63.
• Basu P, Roychowdhury S, Bafna UD, Chaudhury S, Kothari S, Sekhon R, Saranath D, Biswas S, Gronn P, Silva I, Siddiqi M. Human papillomavirus genotype distribution in cervical cancer in India: results from a multi-center study. Asian Pac J Cancer Prev. 2009 Jan 1;10(1):27-34.